Navigation Links
Figure Skater Peggy Fleming Teams With HealthSaver: Healthy Sleep Tips for a New You in 2008
Date:3/4/2008

>

-- Without sleep, bodies lose the opportunity to conduct many vital

functions that maintain health. For example, during sleep our bodies

produce hormones that help fight infection and repair cells and tissue.

-- The nervous system and immune system will not function properly without

sleep. Neurons also use this time to shut down and adjust back to

working order.

-- Even our memory is affected by sleep. The part of the brain that

maintains memory is in fact very active during non-waking hours.

Sleep-wake Cycle

-- In order to keep your sleep-wake cycle in order, it is best to go to

bed and wake up at the same time every day, including weekends. If you

lose sleep during the weekends, you develop a "sleep debt" that

eventually will need to be repaid.

-- To alert your body that it's time to go to bed, follow a consistent

nighttime routine. Prepare your body for sleep with such relaxing

activities as reading or listening to soothing music.

-- Not everyone requires seven to nine hours of sleep each night. Some

people require only five, others 10. To find out how much sleep your

body needs, assess how you feel after different amounts of sleep. Pay

attention to your energy level, productivity and general well-being.

Make Changes

-- Lifestyle factors play a major role in sleep quality. Among them is

regular exercise, which helps provide deeper sleep. Exercise will also

help you fall asleep quicker, leaving you rested and ready for your

day.

-- Mental health and sleep have a great effect on one another. An

estimated 65 percent of Americans lose sleep because of stress.

Depression, in turn, can also lead to insomnia.

-- A proper sleeping environment is a quiet, dark room free of

interruption. Abnormally high or low temperatures will
'/>"/>

SOURCE HealthSaver
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Figure Skater Peggy Fleming, HealthSaver Says: Take Pains For Back Strains, 2nd Most Common Doctor Complaint
2. Figure Skater Peggy Fleming Teams with HealthSaver: Raise Healthy Children Through Active Parenting
3. Figure Skater Peggy Fleming Teams With HealthSaver: Cook Your Way to a Healthy Diet
4. Figure Skater Peggy Fleming Teams with HealthSaver: Heart Healthy Living
5. Patients of Courage Transcend Physical Disfigurement, Help Others
6. Global Summit on AIDS & The Church Calls for Public, Private and Parish Sectors To Unite in Response to Worldwide Pandemic: Pastor Rick and Kay Warren Host More Than 1,700 at Event Featuring International Dignitaries, Political Figures and International E
7. Figure Skater Peggy Fleming Teams with HealthSaver: A New Year, A New You
8. Children who have an active father figure have fewer psychological and behavioral problems
9. Digital Healthcare Announces Dr. Michael Fleming Joins Executive Team as Medical Director
10. National Osteoporosis Foundation Teams Up With Ladies Home Journal Magazine to Launch a 10-city Mall Walk Tour
11. Teamsters Applaud Passage of Legislation to Protect Workers From Diacetyl Exposure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)... Though the number of jobs created i... companies reported a different kind of slowdown: ...s months. , Seattle, WA (...created in the medical field slowed in June overal...ind of slowdown that will be music to the ears of ...
(Date:7/25/2008)... supporting the US Department of Defense and Feder... Phoenix. Operation Golden Phoenix is a, four-da...ned to assist, federal, state and local agencies w...os. Dataline is providing a vital, ad-hoc, secure ... use during the exercise., NORFOLK, Va., July 25 ...
(Date:7/25/2008)...elationship Based on Significant Improvements in M...MDdatacor, Inc., a leader in health,care quality m..., today,announced it has entered into a long-term ...rt Wellmark,s Collaboration on Quality(SM) Incent ...ion between Wellmark and,primary care clinicians t...
(Date:7/25/2008)...URG, Ill., July 25 /PRNewswire/ -- Sagent Pharmace...utical company, today announced that it,has launch...arrhythmic,indicated for the treatment and prophyl...ion and hemodynamically unstable ventricular,tachy... heart beat.,Sagent,s amiodarone HCl injection wil...
Breaking Medicine News(10 mins):Health News:The MedZilla Report: June 2008 Employment Outlook for Biotech/Pharma/Health 2Health News:The MedZilla Report: June 2008 Employment Outlook for Biotech/Pharma/Health 3Health News:Dataline Announces Participation in Operation Golden Phoenix 2Health News:Dataline Announces Participation in Operation Golden Phoenix 3Health News:MDdatacor Extends Contract with Wellmark, Inc. 2Health News:MDdatacor Extends Contract with Wellmark, Inc. 3Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 2Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 3
...s of energy loss during aerobic exercises and this...w our bodies react to exercise programs is genetic...cising like the level of blood glucose in the body...publishing the works of scientists from Washington...
...dies, a part of the Zydus group, has launched Flud...onic lymphocytic leukemia. Chronic Lymphocytic Leu...a serious, progressive disease, which at present h...very uncommon in young people and becomes progress...
...s that the smokers may differ in their cravings// ... to smoking. Researchers have found that the urge ... smokers according to the brain responses to the s...e University Medical Center had looked into the br...
...nts to produce vaccines and other treatments for m...nd they hope to start clinical trials by the year ...will be of greatest benefit to developing nations ...very poor at the same time keeping in mind that hu...
Other Medicine News:Health News:Producing Vaccines from genetically modified crops 2
(Date:7/22/2008)...pment Initiative bring MJFF,s,current active indus...,2009, NEW YORK, July 22 /PRNewswire-USNewswire/...ansformative treatments and a cure for Parkinson,s...son,s Research has awarded,$2.7 million in total f...were granted under MJFF,s Therapeutics Development...
(Date:7/22/2008)...acy of Treating Patients with ...GIN-SI, South Korea, July 22 /-,Jenne... and its South,Korean partner Green Cross Corp., a...clinical trial of its first-in-class lead product ...rated and resulted in clear,anti-cancer efficacy i...
(Date:7/22/2008)...dra(R) Resulted in Significant, Reductions in A1C ...orithm Used, BRI...om the "Adjust to,Target in Type 2 Diabetes: Compa...ng for Adjustment of Mealtime Insulin Glulisine" s...ciation,s (ADA) medical journal,Diabetes Care. Th...
(Date:7/22/2008)...RNewswire/ -- Hyperion,Therapeutics, Inc. today an...n its Phase 1/2 clinical trial to evaluate the saf...f HPN-100 (formally called GT4P) versus,BUPHENYL(R...cle disorders,(UCD). The company plans to announce...ar., (Logo: http://www.newscom.com/cgi-bin/prnh/...
Breaking Medicine Technology:Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 2Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 4Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 2Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 4Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 2Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 3GenOdyssee Receives Notice of Allowance from U S Patent Office for Improved Interferon Alpha Aimed at Hepatitis C 11888 1GenOdyssee Receives Notice of Allowance from U S Patent Office for Improved Interferon Alpha Aimed at Hepatitis C 11888 2GenOdyssee Receives Notice of Allowance from U S Patent Office for Improved Interferon Alpha Aimed at Hepatitis C 11888 3St Valentines Day Wishes 3A Perfume 3F Jewelry 3F Labiaplasty 3F 11886 1St Valentines Day Wishes 3A Perfume 3F Jewelry 3F Labiaplasty 3F 11886 2Sanofi Pasteur and Statens Serum Institut Team Up Against Tuberculosis 3284 1Sanofi Pasteur and Statens Serum Institut Team Up Against Tuberculosis 3284 2Sanofi Pasteur and Statens Serum Institut Team Up Against Tuberculosis 3284 3Sanofi Pasteur and Statens Serum Institut Team Up Against Tuberculosis 3284 4Pharmaxis to Apply to Market Bronchitol in Australia 3283 1Pharmaxis to Apply to Market Bronchitol in Australia 3283 2Pharmaxis to Apply to Market Bronchitol in Australia 3283 3
...n three investigational,agents (VEGF Trap, S-1 and...SCO meeting, BRIDGEWATER, N.J., May 29, 2007 /PRNe...y that a total of 375 abstracts,indicative of its ...d Annual Meeting of the American Society of Clinic... 2007). The results from key,studies involving the...
...INNOVIVE Pharmaceuticals,Inc. (OTCBB: IVPH) today...of INNO-406, an orally bioavailable dual Bcr-Abl a...r,treatment-intolerant chronic myelogenous leukemi...of Clinical Oncology Annual,Meeting. The meeting t...hicago, Illinois., Information related to the pres...
Other Medicine Technology:Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 2Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 3Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 4Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 5Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 6Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 7Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 8Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 9Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 10Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 11Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 12Innovive Pharmaceuticals to Present Interim Data from Phase I Study,of INNO-406 at the American Society of Clinical Oncology Annual,Meeting 2
FM Series Oxygen Flowmeters with Power Take Off, ,Options: , For security chain, add suffix S to model number. Example: FM107S. , For Canadian Color-Code, add suffix C to model number. Example: FM10
FM Style Neonatal Flowmeters (Brass Body)
...te offers innovative proficiency testing solutions...upport. As a result, API is one of the largest pro...12,000 laboratories enrolled. Here are just some o...roficiency Testing, Free CME/CMLE Credits Spons...
... for the professional ophthalmic photographer. Int... slit and background illumination, all controlled ... slit lamp joystick, as well as adaptors allowing ...nal level digital and 35 mm cameras, ensure ophtha...
Medicine Products: